These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9717867)

  • 21. Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.
    Mundo E; Guglielmo E; Bellodi L
    Int Clin Psychopharmacol; 1998 Sep; 13(5):219-24. PubMed ID: 9817627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive therapy versus fluvoxamine as a second-step treatment in obsessive-compulsive disorder nonresponsive to first-step behavior therapy.
    van Balkom AJ; Emmelkamp PM; Eikelenboom M; Hoogendoorn AW; Smit JH; van Oppen P
    Psychother Psychosom; 2012; 81(6):366-74. PubMed ID: 22964609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study.
    Nakao T; Nakagawa A; Yoshiura T; Nakatani E; Nabeyama M; Yoshizato C; Kudoh A; Tada K; Yoshioka K; Kawamoto M; Togao O; Kanba S
    Biol Psychiatry; 2005 Apr; 57(8):901-10. PubMed ID: 15820711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assignment refusal and its relation to outcome in a randomized controlled trial comparing Cognitive Therapy and Fluvoxamine in treatment-resistant patients with obsessive compulsive disorder.
    Landsheer JA; Smit JH; van Oppen P; van Balkom AJ
    Psychiatry Res; 2015 Mar; 226(1):198-203. PubMed ID: 25618476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
    Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cholesterol in patients with obsessive compulsive disorder during treatment with behavior therapy and SSRI or placebo.
    Peter H; Tabrizian S; Hand I
    Int J Psychiatry Med; 2000; 30(1):27-39. PubMed ID: 10900559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences between early and late drop-outs from treatment for obsessive-compulsive disorder.
    Aderka IM; Anholt GE; van Balkom AJ; Smit JH; Hermesh H; Hofmann SG; van Oppen P
    J Anxiety Disord; 2011 Oct; 25(7):918-23. PubMed ID: 21664103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics.
    Reznik I; Sirota P
    J Clin Psychopharmacol; 2000 Aug; 20(4):410-6. PubMed ID: 10917401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Can the efficacy of behavioral and cognitive therapy for obsessive compulsive disorder be augmented by innovative computerized adjuvant?].
    Morgiève M; N'Diaye K; Clair AH; Pelissolo A; Mallet L
    Encephale; 2016 Oct; 42(5):402-409. PubMed ID: 27109326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response versus remission in obsessive-compulsive disorder.
    Simpson HB; Huppert JD; Petkova E; Foa EB; Liebowitz MR
    J Clin Psychiatry; 2006 Feb; 67(2):269-76. PubMed ID: 16566623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluvoxamine in the treatment of compulsive buying.
    Black DW; Monahan P; Gabel J
    J Clin Psychiatry; 1997 Apr; 58(4):159-63. PubMed ID: 9164426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Yale-Brown Obsessive Compulsive Scale. II. Validity.
    Goodman WK; Price LH; Rasmussen SA; Mazure C; Delgado P; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1989 Nov; 46(11):1012-6. PubMed ID: 2510699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of fluvoxamine combined with extended-release methylphenidate on treatment-refractory obsessive-compulsive disorder].
    Zheng H; Jia F; Guo G; Quan D; Li G; Huang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1230-1235. PubMed ID: 30643068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sudden gains in the treatment of obsessive-compulsive disorder.
    Aderka IM; Anholt GE; van Balkom AJ; Smit JH; Hermesh H; van Oppen P
    Psychother Psychosom; 2012; 81(1):44-51. PubMed ID: 22116471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.
    Goodman WK; Price LH; Rasmussen SA; Delgado PL; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1989 Jan; 46(1):36-44. PubMed ID: 2491940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive therapy with obsessive-compulsive disorder: a comparative evaluation.
    Emmelkamp PM; Beens H
    Behav Res Ther; 1991; 29(3):293-300. PubMed ID: 1679324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparisons among the Yale-Brown Obsessive-Compulsive Scale, compulsion checklist, and other measures of obsessive-compulsive disorder.
    Nakagawa A; Marks IM; Takei N; De Araujo LA; Ito LM
    Br J Psychiatry; 1996 Jul; 169(1):108-12. PubMed ID: 8818378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of severe obsessive-compulsive disorder with fluvoxamine.
    Price LH; Goodman WK; Charney DS; Rasmussen SA; Heninger GR
    Am J Psychiatry; 1987 Aug; 144(8):1059-61. PubMed ID: 3111279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.